SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
赵医生
Lv1
30 积分
2022-11-30 加入
最近求助
最近应助
互助留言
Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis
1个月前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
1个月前
已完结
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
1个月前
已完结
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
2个月前
已完结
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
2个月前
已完结
Solid stress impairs lymphocyte infiltration into lymph-node metastases
2个月前
已完结
Spatial predictors of immunotherapy response in triple-negative breast cancer
2个月前
已完结
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
2个月前
已完结
The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients
3个月前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
3个月前
已完结
没有进行任何应助
感谢
4个月前
感谢
8个月前
感谢
8个月前
速度真快
11个月前
感谢
11个月前
感谢
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论